Medical Marketing & Media

Merz Aesthetics celebrates Xeomin’s 15-year anniversary with refreshed brand campaign

After spending the past few years centering its Beauty on Your Terms campaign around celebrities, Merz is now positioning the brand around everyday consumers.

Merz Aesthetics Celebrates 15 Years of XEOMIN(R) (incobotulinumtoxinA) in the U.S. with One Year of Free Treatments Sweepstakes & New Campaign

Merz Aesthetics, the world's largest dedicated medical aesthetics business, celebrates 15 years since its flagship brand XEOMIN(R) was first approved for aesthetic use by the U.S. Food and Drug ...
Business Wire

Merz Therapeutics Announces First Patients Enrolled in Two Phase III Trials Investigating XEOMIN ® (incobotulinumtoxinA) for Migraine Prevention

“The enrollment of the first patients in the MINT trials marks an important milestone as we aim to address persistent gaps in migraine care by advancing a new neurotoxin option for patients.” MINT-E ...
Cosmopolitan

Breaking Down All the Types of Botox: Botox, Xeomin, Dysport, Jeuveau, and Daxxify

When I say I’ve been getting Botox my entire adult life, I’m not exaggerating one bit—I started at the ripe, young age of 19 to help prevent wrinkles from forming, and I’ve honestly never looked back.
Eagle-Tribune

Merz Therapeutics Announces First Patients Enrolled in Two Phase III Trials Investigating XEOMIN® (incobotulinumtoxinA) for Migraine Prevention

Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced that the first patients have been enrolled in two global Phase III clinical trials — MINT-E ( ...